» Articles » PMID: 37502403

The Potential of Fungi in the Bioremediation of Pharmaceutically Active Compounds: a Comprehensive Review

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2023 Jul 28
PMID 37502403
Authors
Affiliations
Soon will be listed here.
Abstract

The ability of fungal species to produce a wide range of enzymes and metabolites, which act synergistically, makes them valuable tools in bioremediation, especially in the removal of pharmaceutically active compounds (PhACs) from contaminated environments. PhACs are compounds that have been specifically designed to treat or alter animal physiological conditions and they include antibiotics, analgesics, hormones, and steroids. Their detrimental effects on all life forms have become a source of public outcry due their persistent nature and their uncontrolled discharge into various wastewater effluents, hospital effluents, and surface waters. Studies have however shown that fungi have the necessary metabolic machinery to degrade PhACs in complex environments, such as soil and water, in addition they can be utilized in bioreactor systems to remove PhACs. In this regard, this review highlights fungal species with immense potential in the biodegradation of PhACs, their enzymatic arsenal as well as the probable mechanism of biodegradation. The challenges encumbering the real-time application of this promising bioremediative approach are also highlighted, as well as the areas of improvement and future perspective. In all, this paper points researchers to the fact that fungal bioremediation is a promising strategy for addressing the growing issue of pharmaceutical contamination in the environment and can help to mitigate the negative impacts on ecosystems and human health.

Citing Articles

Impact of veterinary pharmaceuticals on environment and their mitigation through microbial bioremediation.

Saeed H, Padmesh S, Singh A, Nandy A, Singh S, Deshwal R Front Microbiol. 2024; 15:1396116.

PMID: 39040911 PMC: 11262132. DOI: 10.3389/fmicb.2024.1396116.


Searching for Chemical Agents Suppressing Substrate Microbiota in White-Rot Fungi Large-Scale Cultivation.

Maruska A, Mickiene R, Kaskoniene V, Grigiskis S, Stankevicius M, Drevinskas T Microorganisms. 2024; 12(6).

PMID: 38930624 PMC: 11206069. DOI: 10.3390/microorganisms12061242.


Tuning interdomain conjugation to enable population modification in yeasts.

Stindt K, McClean M mSystems. 2024; 9(6):e0005024.

PMID: 38747597 PMC: 11326116. DOI: 10.1128/msystems.00050-24.


White Rot Fungi as Tools for the Bioremediation of Xenobiotics: A Review.

Torres-Farrada G, Thijs S, Rineau F, Guerra G, Vangronsveld J J Fungi (Basel). 2024; 10(3).

PMID: 38535176 PMC: 10971306. DOI: 10.3390/jof10030167.

References
1.
Gros M, Cruz-Morato C, Marco-Urrea E, Longree P, Singer H, Sarra M . Biodegradation of the X-ray contrast agent iopromide and the fluoroquinolone antibiotic ofloxacin by the white rot fungus Trametes versicolor in hospital wastewaters and identification of degradation products. Water Res. 2014; 60:228-241. DOI: 10.1016/j.watres.2014.04.042. View

2.
Ferrando-Climent L, Cruz-Morato C, Marco-Urrea E, Vicent T, Sarra M, Rodriguez-Mozaz S . Non conventional biological treatment based on Trametes versicolor for the elimination of recalcitrant anticancer drugs in hospital wastewater. Chemosphere. 2015; 136:9-19. DOI: 10.1016/j.chemosphere.2015.03.051. View

3.
Deshmukh R, Khardenavis A, Purohit H . Diverse Metabolic Capacities of Fungi for Bioremediation. Indian J Microbiol. 2016; 56(3):247-64. PMC: 4920763. DOI: 10.1007/s12088-016-0584-6. View

4.
Esterhuizen-Londt M, Schwartz K, Pflugmacher S . Using aquatic fungi for pharmaceutical bioremediation: Uptake of acetaminophen by Mucor hiemalis does not result in an enzymatic oxidative stress response. Fungal Biol. 2016; 120(10):1249-57. DOI: 10.1016/j.funbio.2016.07.009. View

5.
Shleev S, Morozova O, Nikitina O, Gorshina E, Rusinova T, Serezhenkov V . Comparison of physico-chemical characteristics of four laccases from different basidiomycetes. Biochimie. 2004; 86(9-10):693-703. DOI: 10.1016/j.biochi.2004.08.005. View